Pacemaker Lead Placement via Transmural Approach in an Adult With Palliated Single Ventricle Heart Disease
Robert D Tunks1, John L Myers1, Mark H Cohen1
1Penn State Health Children's Hospital, 12311The Milton S. Hershey Medical Center, Hershey, PA, USA.
World Journal for Pediatric & Congenital Heart Surgery
|January 12, 2022
Summary
Single ventricle patients often need pacemakers. A novel transmural approach using 3D imaging and models guided endocardial lead placement, offering a new solution for pacemaker management in these complex patients.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Device Technology
Background:
- Palliated single ventricle patients often require epicardial pacemakers for dysrhythmia management.
- Repeated device hardware replacement is a significant challenge due to lead issues and device failure.
- 3-dimensional imaging offers potential for novel interventional approaches.
Purpose of the Study:
- To describe a novel endocardial pacemaker lead placement technique in a patient with extracardiac Fontan circulation.
- To evaluate the utility of 3D-printed models for procedural guidance in pacemaker implantation.
- To present an alternative strategy for managing pacemaker lead issues in single ventricle physiology.
Main Methods:
- A patient with extracardiac Fontan circulation underwent pacemaker lead implantation.
- A transmural approach was utilized for endocardial lead placement.
- A 3D-printed cardiac model was used for pre-procedural planning and guidance.
Main Results:
- Successful placement of an endocardial atrial pacemaker lead was achieved.
- The 3D-printed model facilitated procedural navigation and lead positioning.
- This approach potentially mitigates challenges associated with epicardial lead replacement.
Conclusions:
- Transmural, image-guided endocardial lead placement is a feasible alternative for pacemaker management in single ventricle patients.
- 3D-printed models enhance procedural accuracy and safety for complex cardiac interventions.
- This technique may reduce the need for repeated epicardial device hardware replacement.


